[Elsevier] LANCET - Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study |
|
This post will be closed automatically in 2026-06-28 19:13
Reward10points
|
post
reply
points
2305
50
Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration
10
Farmers＊ cooperatives and smallholder farmers＊ access to credit: Evidence from China
10
Dynamic behaviour of sandwich panel-reinforced concrete composite slabs under low-velocity impact
10
High-throughput phenotyping using VIS/NIR spectroscopy in the classification of soybean genotypes for grain yield and industrial traits
10
Image-level multi-label retinal disease classification with a novel classification head
